Cost-Effectiveness Analysis 2.0.

Neumann, Peter J; Sanders, Gillian D

Neumann, Peter J; Sanders, Gillian D.

Affiliation

Neumann PJ; From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston (P.J.N.); and the Duke Clinical Research Institute, Duke University, Durham, NC (G.D.S.).
Sanders GD; From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston (P.J.N.); and the Duke Clinical Research Institute, Duke University, Durham, NC (G.D.S.).

N Engl J Med ; 376(3): 203-205, 2017 Jan 19.

Article in En | MEDLINE | ID: mdl-28099837

Subject(s)

Cost-Benefit Analysis/methods; Health Care Costs; Cost-Benefit Analysis/ethics; Cost-Benefit Analysis/standards; Guidelines as Topic; Health Care Rationing/economics; Health Care Rationing/ethics; Humans; Quality-Adjusted Life Years; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Costs / Cost-Benefit Analysis Type of study: Guideline / Health_economic_evaluation Limits: Humans Country/Region as subject: America do norte Language: En Journal: N Engl J Med Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google